2025-03-012026-02-282026-02-28false13179266TIGA HEALTH LIMITED2026-10-30falseiso4217:GBPxbrli:pure131792662025-02-28131792662026-02-28131792662025-03-012026-02-28131792662024-02-29131792662025-02-28131792662024-03-012025-02-2813179266bus:SmallEntities2025-03-012026-02-2813179266bus:AuditExempt-NoAccountantsReport2025-03-012026-02-2813179266bus:AbridgedAccounts2025-03-012026-02-2813179266bus:PrivateLimitedCompanyLtd2025-03-012026-02-2813179266core:WithinOneYear2026-02-2813179266core:AfterOneYear2026-02-2813179266core:WithinOneYear2025-02-2813179266core:AfterOneYear2025-02-2813179266core:ShareCapital2026-02-2813179266core:SharePremium2026-02-2813179266core:RevaluationReserve2026-02-2813179266core:OtherReservesSubtotal2026-02-2813179266core:RetainedEarningsAccumulatedLosses2026-02-2813179266core:ShareCapital2025-02-2813179266core:SharePremium2025-02-2813179266core:RevaluationReserve2025-02-2813179266core:OtherReservesSubtotal2025-02-2813179266core:RetainedEarningsAccumulatedLosses2025-02-2813179266core:LandBuildings2026-02-2813179266core:PlantMachinery2026-02-2813179266core:Vehicles2026-02-2813179266core:FurnitureFittings2026-02-2813179266core:OfficeEquipment2026-02-2813179266core:NetGoodwill2026-02-2813179266core:IntangibleAssetsOtherThanGoodwill2026-02-2813179266core:ListedExchangeTraded2026-02-2813179266core:UnlistedNon-exchangeTraded2026-02-2813179266core:LandBuildings2025-02-2813179266core:PlantMachinery2025-02-2813179266core:Vehicles2025-02-2813179266core:FurnitureFittings2025-02-2813179266core:OfficeEquipment2025-02-2813179266core:NetGoodwill2025-02-2813179266core:IntangibleAssetsOtherThanGoodwill2025-02-2813179266core:ListedExchangeTraded2025-02-2813179266core:UnlistedNon-exchangeTraded2025-02-2813179266core:LandBuildings2025-03-012026-02-2813179266core:PlantMachinery2025-03-012026-02-2813179266core:Vehicles2025-03-012026-02-2813179266core:FurnitureFittings2025-03-012026-02-2813179266core:OfficeEquipment2025-03-012026-02-2813179266core:NetGoodwill2025-03-012026-02-2813179266core:IntangibleAssetsOtherThanGoodwill2025-03-012026-02-2813179266core:ListedExchangeTraded2025-03-012026-02-2813179266core:UnlistedNon-exchangeTraded2025-03-012026-02-2813179266core:MoreThanFiveYears2025-03-012026-02-2813179266core:Non-currentFinancialInstruments2026-02-2813179266core:Non-currentFinancialInstruments2025-02-2813179266dpl:CostSales2025-03-012026-02-2813179266dpl:DistributionCosts2025-03-012026-02-2813179266core:LandBuildings2025-03-012026-02-2813179266core:PlantMachinery2025-03-012026-02-2813179266core:Vehicles2025-03-012026-02-2813179266core:FurnitureFittings2025-03-012026-02-2813179266core:OfficeEquipment2025-03-012026-02-2813179266dpl:AdministrativeExpenses2025-03-012026-02-2813179266core:NetGoodwill2025-03-012026-02-2813179266core:IntangibleAssetsOtherThanGoodwill2025-03-012026-02-2813179266dpl:GroupUndertakings2025-03-012026-02-2813179266dpl:ParticipatingInterests2025-03-012026-02-2813179266dpl:GroupUndertakingscore:ListedExchangeTraded2025-03-012026-02-2813179266core:ListedExchangeTraded2025-03-012026-02-2813179266dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-03-012026-02-2813179266core:UnlistedNon-exchangeTraded2025-03-012026-02-2813179266dpl:CostSales2024-03-012025-02-2813179266dpl:DistributionCosts2024-03-012025-02-2813179266core:LandBuildings2024-03-012025-02-2813179266core:PlantMachinery2024-03-012025-02-2813179266core:Vehicles2024-03-012025-02-2813179266core:FurnitureFittings2024-03-012025-02-2813179266core:OfficeEquipment2024-03-012025-02-2813179266dpl:AdministrativeExpenses2024-03-012025-02-2813179266core:NetGoodwill2024-03-012025-02-2813179266core:IntangibleAssetsOtherThanGoodwill2024-03-012025-02-2813179266dpl:GroupUndertakings2024-03-012025-02-2813179266dpl:ParticipatingInterests2024-03-012025-02-2813179266dpl:GroupUndertakingscore:ListedExchangeTraded2024-03-012025-02-2813179266core:ListedExchangeTraded2024-03-012025-02-2813179266dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-03-012025-02-2813179266core:UnlistedNon-exchangeTraded2024-03-012025-02-2813179266core:NetGoodwill2026-02-2813179266core:IntangibleAssetsOtherThanGoodwill2026-02-2813179266core:LandBuildings2026-02-2813179266core:PlantMachinery2026-02-2813179266core:Vehicles2026-02-2813179266core:FurnitureFittings2026-02-2813179266core:OfficeEquipment2026-02-2813179266core:AfterOneYear2026-02-2813179266core:WithinOneYear2026-02-2813179266core:ListedExchangeTraded2026-02-2813179266core:UnlistedNon-exchangeTraded2026-02-2813179266core:ShareCapital2026-02-2813179266core:SharePremium2026-02-2813179266core:RevaluationReserve2026-02-2813179266core:OtherReservesSubtotal2026-02-2813179266core:RetainedEarningsAccumulatedLosses2026-02-2813179266core:NetGoodwill2025-02-2813179266core:IntangibleAssetsOtherThanGoodwill2025-02-2813179266core:LandBuildings2025-02-2813179266core:PlantMachinery2025-02-2813179266core:Vehicles2025-02-2813179266core:FurnitureFittings2025-02-2813179266core:OfficeEquipment2025-02-2813179266core:AfterOneYear2025-02-2813179266core:WithinOneYear2025-02-2813179266core:ListedExchangeTraded2025-02-2813179266core:UnlistedNon-exchangeTraded2025-02-2813179266core:ShareCapital2025-02-2813179266core:SharePremium2025-02-2813179266core:RevaluationReserve2025-02-2813179266core:OtherReservesSubtotal2025-02-2813179266core:RetainedEarningsAccumulatedLosses2025-02-2813179266core:NetGoodwill2024-02-2913179266core:IntangibleAssetsOtherThanGoodwill2024-02-2913179266core:LandBuildings2024-02-2913179266core:PlantMachinery2024-02-2913179266core:Vehicles2024-02-2913179266core:FurnitureFittings2024-02-2913179266core:OfficeEquipment2024-02-2913179266core:AfterOneYear2024-02-2913179266core:WithinOneYear2024-02-2913179266core:ListedExchangeTraded2024-02-2913179266core:UnlistedNon-exchangeTraded2024-02-2913179266core:ShareCapital2024-02-2913179266core:SharePremium2024-02-2913179266core:RevaluationReserve2024-02-2913179266core:OtherReservesSubtotal2024-02-2913179266core:RetainedEarningsAccumulatedLosses2024-02-2913179266core:AfterOneYear2025-03-012026-02-2813179266core:WithinOneYear2025-03-012026-02-2813179266core:Non-currentFinancialInstrumentscore:CostValuation2025-03-012026-02-2813179266core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-012026-02-2813179266core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-012026-02-2813179266core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-012026-02-2813179266core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-012026-02-2813179266core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-012026-02-2813179266core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-012026-02-2813179266core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-012026-02-2813179266core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-012026-02-2813179266core:Non-currentFinancialInstrumentscore:CostValuation2026-02-2813179266core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-02-2813179266core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-02-2813179266core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-02-2813179266core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-02-2813179266core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-02-2813179266core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-02-2813179266core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-02-2813179266core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-02-2813179266core:Non-currentFinancialInstrumentscore:CostValuation2025-02-2813179266core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-02-2813179266core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-02-2813179266core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-02-2813179266core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-02-2813179266core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-02-2813179266core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-02-2813179266core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-02-2813179266core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-02-2813179266bus:Director12025-03-012026-02-2813179266bus:Director22025-03-012026-02-28

TIGA HEALTH LIMITED

Registered Number
13179266
(England and Wales)

Unaudited Financial Statements for the Year ended
28 February 2026

TIGA HEALTH LIMITED
Company Information
for the year from 1 March 2025 to 28 February 2026

Directors

KARACA, Alpaslan Mete
YASASIN, Hamit

Company Secretary

EBS CORPORATE SERVICES LIMITED

Registered Address

Innovation Centre
Gallows Hill
Warwick
CV34 6UW

Registered Number

13179266 (England and Wales)
TIGA HEALTH LIMITED
Balance Sheet as at
28 February 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets3417667
417667
Current assets
Stocks24,868130,000
Debtors8,8202,128
Cash at bank and on hand90,154158,407
123,842290,535
Creditors amounts falling due within one year(120,327)(169,672)
Net current assets (liabilities)3,515120,863
Total assets less current liabilities3,932121,530
Net assets3,932121,530
Capital and reserves
Called up share capital1,0001,000
Profit and loss account2,932120,530
Shareholders' funds3,932121,530
The financial statements were approved and authorised for issue by the Board of Directors on 30 October 2026, and are signed on its behalf by:
YASASIN, Hamit
Director
Registered Company No. 13179266
TIGA HEALTH LIMITED
Notes to the Financial Statements
for the year ended 28 February 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Office Equipment3
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
2.Average number of employees

20262025
Average number of employees during the year11
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 March 25750
At 28 February 26750
Depreciation and impairment
At 01 March 2583
Charge for year250
At 28 February 26333
Net book value
At 28 February 26417
At 28 February 25667